Stig Linder
Professor
Oncology-Pathology
Karolinska Institutet
Sweden
Biography
Dr. Stig Linder is currently working as in the Department of Oncology-Pathology (OnkPat), K7, , . Stig Linder research interest includes Molecular Cancer Pharmacology and has successfully completed their Administrative responsibilities. Stig Linder has authored of many research articles related to Molecular Cancer Pharmacology.
Research Interest
Molecular Cancer Pharmacology
Publications
-
Brnjic S, Olofsson MH, Havelka AM, Linder S. Chemical biology suggests a role for calcium signaling in mediating sustained JNK activation during apoptosis. Molecular BioSystems. 2010;6(5):767-74.
-
Fayad W, Brnjic S, Berglind D, Blixt S, Shoshan MC, Berndtsson M, Olofsson MH, Linder S. Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a threeâ€dimensional carcinoma culture model. International journal of cancer. 2009 Nov 15;125(10):2450-5.
-
Linder S, Olofsson MH, Herrmann R, Ulukaya E. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert review of molecular diagnostics. 2010 Apr 1;10(3):353-9.
